Global Hypodermic Needle Market Outlook and Forecast 2019-2024 - Technological Advancements in Hypodermic Needle-based Drug Delivery Will Boost the Market - ResearchAndMarkets.com

The "Global Hypodermic Needle Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

The global hypodermic needle market is evaluated at US$ 2,489.851 million for the year 2018.

The market is expected to show significant growth during the forecast period. The growth may be attributed to the rising prevalence of chronic diseases such as diabetes and cancer across the globe. Technological advancements in hypodermic needle-based drug delivery will also boost the market for hypodermic needle.

However, availability of the alternative modes of drug delivery might restrict the growth of the market. The growth of the market may also be hampered by the lack of awareness regarding the use of hypodermic needles in the emerging economies during the given time frame.

This report is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.

The global hypodermic needle market has been segmented based on type, application, end-user, and geography. By type, the market has been segmented into safety hypodermic needle, non-safety hypodermic needle. By application the market is segmented into drug delivery, vaccination, body fluid collection. By the end-user, the market is segmented into hospitals and clinics, ambulatory care centers, diagnostic centers and others.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the global hypodermic needle market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global hypodermic needle market.

Segmentation

By Type

• Safety Hypodermic Needle
• Non-Safety Hypodermic Needle

By Application

• Drug Delivery
• Vaccination
• Body Fluid Collection

By End-user

• Hospitals & Clinics
• Ambulatory Care Centres
• Diagnostic Centres
• Others

By Geography

North America

• United States
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Middle East & Africa

• Saudi Arabia
• Israel
• Others

Asia-Pacific

• China
• Japan
• India
• South Korea
• Others

Companies Mentioned

• Connecticut Hypodermics Inc.
• Nipro Medical
• Becton, Dickinson and Company
• Victor - G. & Company
• Vita Needle Company
• B. Braun Melsungen AG
• Cardinal Health
• Terumo Medical N.V.
• Smiths Group plc

For more information about this report visit https://www.researchandmarkets.com/r/rcxsiu

View source version on businesswire.com: https://www.businesswire.com/news/home/20191122005263/en/